Véronique Lorgis
Institut de Cancérologie de Bourgogne(FR)
Publications by Year
Research Areas
Breast Cancer Treatment Studies, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Glioma Diagnosis and Treatment
Most-Cited Works
- → Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort(2018)277 cited
- → The molecular landscape of glioma in patients with Neurofibromatosis 1(2018)207 cited
- → Contemporary outcomes of metastatic breast cancer among 22,000 women from the multicentre ESME cohort 2008–2016(2020)186 cited
- → Intrathecal liposomal cytarabine plus systemic therapy versus systemic chemotherapy alone for newly diagnosed leptomeningeal metastasis from breast cancer(2019)102 cited
- → Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour(2011)74 cited
- → Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)(2021)73 cited
- → Paclitaxel plus bevacizumab or paclitaxel as first-line treatment for HER2-negative metastatic breast cancer in a multicenter national observational study(2016)72 cited
- → Identification of Biomarkers Including 18FDG-PET/CT for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer(2015)68 cited
- Prolonged administration of adjuvant temozolomide improves survival in adult patients with glioblastoma.(2013)
- → FOLFIRI plus bevacizumab as a second-line therapy for metastatic intrahepatic cholangiocarcinoma(2015)63 cited